Media Releases

Dec 9 -  Immunovaccine Receives Clearance from FDA to Proceed with Phase 1 Clinical Trial for its Therapeutic Cancer Vaccine
Nov 23 -  Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health
Nov 10 -  Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute
Nov 2 -  Immunovaccine Inc. Signs Cato Research Canada, Inc. as Clinical Trial CRO
Oct 29 -  Immunovaccine Expands Collaboration with Defence Research & Development Canada
Oct 27 -  Immunovaccine Inc. Appoints Communications Director
Oct 22 -  Immunovaccine Inc. Revises Escrow Securities Schedule
Oct 5 -  Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol “IMV”
Sep 28 -  ImmunoVaccine Technologies Appoints New CFO
Aug 5 -  ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery
Jul 23 -  ImmunoVaccine Technologies Secures National Research Council of Canada Industrial Research Assistance Program Funding
Jul 14 -  ImmunoVaccine Technologies Licenses Immunotope’s Breast, Ovarian and Prostate Cancer Antigens
Jul 6 -  ImmunoVaccine Technologies to Develop Pseudomonas Vaccine from Yokohama City University
Jun 12 -  Warwick Kimmins Science Scholarship Awarded
Jun 8 -  Rhino and IVT Announce Proposed Qualifying Transaction
May 26 -  ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
May 20 -  ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax™ with novel MRI Imaging
Apr 14 -  ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canada’s Ability to Deal with Biological Threats
Mar 27 -  ImmunoVaccine Technologies Signs Agreement with La Jolla Institute for Allergy & Immunology to Test the Application of DepoVax™ Technology to Battle Influenza
Feb 25 -  ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
Jan 9 -  ImmunoVaccine Technologies Presents at OneMedPlace Finance Forum